FI964623A0 - Pureskeltavia flubendatsolitabletteja seuraeläimille - Google Patents

Pureskeltavia flubendatsolitabletteja seuraeläimille

Info

Publication number
FI964623A0
FI964623A0 FI964623A FI964623A FI964623A0 FI 964623 A0 FI964623 A0 FI 964623A0 FI 964623 A FI964623 A FI 964623A FI 964623 A FI964623 A FI 964623A FI 964623 A0 FI964623 A0 FI 964623A0
Authority
FI
Finland
Prior art keywords
flubendazole
companion animals
pct
chewable
tablets
Prior art date
Application number
FI964623A
Other languages
English (en)
Swedish (sv)
Other versions
FI118324B (fi
FI964623A (fi
Inventor
Eugene Maria Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI964623A0 publication Critical patent/FI964623A0/fi
Publication of FI964623A publication Critical patent/FI964623A/fi
Application granted granted Critical
Publication of FI118324B publication Critical patent/FI118324B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production
FI964623A 1994-05-20 1996-11-19 Pureskeltavia flubendatsolitabletteja seuraeläimille FI118324B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94201434 1994-05-20
EP94201434 1994-05-20
PCT/EP1995/001801 WO1995031963A1 (en) 1994-05-20 1995-05-12 Chewable flubendazole tablets for companion animals
EP9501801 1995-05-12

Publications (3)

Publication Number Publication Date
FI964623A0 true FI964623A0 (fi) 1996-11-19
FI964623A FI964623A (fi) 1996-11-19
FI118324B FI118324B (fi) 2007-10-15

Family

ID=8216895

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964623A FI118324B (fi) 1994-05-20 1996-11-19 Pureskeltavia flubendatsolitabletteja seuraeläimille

Country Status (23)

Country Link
US (1) US5824336A (fi)
EP (1) EP0760648B1 (fi)
JP (1) JPH10501211A (fi)
AT (1) ATE208611T1 (fi)
AU (1) AU690994B2 (fi)
BR (1) BR9507637A (fi)
CA (1) CA2190357C (fi)
CY (1) CY2255B1 (fi)
CZ (1) CZ290406B6 (fi)
DE (1) DE69523912T2 (fi)
DK (1) DK0760648T3 (fi)
ES (1) ES2167436T3 (fi)
FI (1) FI118324B (fi)
HK (1) HK1010695A1 (fi)
HU (1) HU225958B1 (fi)
IL (1) IL113782A (fi)
NO (1) NO313402B1 (fi)
NZ (1) NZ285766A (fi)
PL (1) PL185332B1 (fi)
PT (1) PT760648E (fi)
SI (1) SI0760648T1 (fi)
WO (1) WO1995031963A1 (fi)
ZA (1) ZA954128B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317560A (en) * 1996-09-20 1998-04-01 Edmund John Hilary Campion Anti-parasite medication for pets
AU7595300A (en) * 1999-09-22 2001-04-24 Akzo Nobel N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20050271708A1 (en) * 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1759692A3 (en) * 2003-03-10 2007-09-12 Novartis AG Taste-masked solid veterinary compositions
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
DK1660104T3 (da) * 2003-08-26 2010-06-21 Shire Holdings Ag Farmaceutisk formulering indeholdende lanthanforbindelser
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
MD20170009A2 (ro) 2012-02-06 2017-07-31 Merial Limited Compoziţii veterinare antiparazitare orale cu conţinut de agenţi activi cu acţiune sistemică, metode şi aplicări ale acestora
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN109010296A (zh) 2012-04-04 2018-12-18 英特维特国际股份有限公司 异噁唑啉化合物的固体口服药物组合物
CA2906295C (en) 2013-03-15 2019-01-22 Argenta Manufacturing Limited Chewable formulation
KR102455648B1 (ko) 2013-07-19 2022-10-19 베링거잉겔하임베트메디카게엠베하 보존된 에테르화된 사이클로덱스트린 유도체 함유 액체 수성 약제학적 조성물
JP6117079B2 (ja) * 2013-10-01 2017-04-19 富士フイルム株式会社 チュアブル錠用組成物及びチュアブル錠
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE944581C (de) * 1953-10-15 1956-06-21 Waldhof Zellstoff Fab Verfahren zur Herstellung einer Pilengrundmasse
AU5957480A (en) * 1979-07-26 1981-01-29 American Cyanamid Company Diethyl carbamazine resinate
US4578268A (en) * 1979-07-26 1986-03-25 American Cyanamid Company Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
JPS5821615A (ja) * 1981-07-29 1983-02-08 Fujisawa Pharmaceut Co Ltd 草食獣の肝蛭症の予防治療剤
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique

Also Published As

Publication number Publication date
BR9507637A (pt) 1997-10-07
HU9603215D0 (en) 1997-01-28
CZ290406B6 (cs) 2002-07-17
EP0760648A1 (en) 1997-03-12
NO313402B1 (no) 2002-09-30
HUT74988A (en) 1997-03-28
NZ285766A (en) 1997-09-22
PL317227A1 (en) 1997-03-17
CA2190357A1 (en) 1995-11-30
IL113782A (en) 1999-08-17
JPH10501211A (ja) 1998-02-03
SI0760648T1 (en) 2002-04-30
CA2190357C (en) 2007-04-17
US5824336A (en) 1998-10-20
CZ333596A3 (en) 1997-02-12
AU690994B2 (en) 1998-05-07
DE69523912D1 (de) 2001-12-20
ATE208611T1 (de) 2001-11-15
EP0760648B1 (en) 2001-11-14
NO964912L (no) 1996-11-19
IL113782A0 (en) 1995-08-31
PT760648E (pt) 2002-04-29
ES2167436T3 (es) 2002-05-16
HK1010695A1 (en) 1999-06-25
NO964912D0 (no) 1996-11-19
DE69523912T2 (de) 2002-06-27
ZA954128B (en) 1996-11-19
WO1995031963A1 (en) 1995-11-30
HU225958B1 (en) 2008-01-28
FI118324B (fi) 2007-10-15
AU2527295A (en) 1995-12-18
CY2255B1 (en) 2003-07-04
FI964623A (fi) 1996-11-19
DK0760648T3 (da) 2002-02-25
PL185332B1 (pl) 2003-04-30

Similar Documents

Publication Publication Date Title
FI964623A0 (fi) Pureskeltavia flubendatsolitabletteja seuraeläimille
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
MA27867A1 (fr) Nouveaux derives de 2h-pyridazine-3-one, compositions pharmaceutiques contenant ces derives et procede de preparation de l'ingredient actif.
BR0215277A (pt) Dicetopiperazinas substituìdas como antagonistas da oxitocina
FI963885A (fi) Pyrimidiini- tai triatsiinikarboksyylihappojohdannaiset käytettäväksi lääkaineina
BR0013313A (pt) Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda
IL165220A0 (en) Novel compounds, their use and preparation
MX2007003307A (es) 4-bencil-1,3-dihidro-imidazol-2-tionas substituidas y no substituidas que actuan como agonistas adrenergicos alfa2 especificos o selectivos y metodos de uso de las mismas.
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
MX9605709A (es) Tabletas masticables de flubendazol para animales de compañia.
ATE247649T1 (de) Disubstituierte biphenyloxazoline
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
GB0003234D0 (en) Method of treatment

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118324

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: ELANCO ANIMAL HEALTH IRELAND LIMITED

Free format text: ELANCO ANIMAL HEALTH IRELAND LIMITED

MA Patent expired